Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range

NCT01529203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Aging

Interventions

DRUG: Botulinum Toxin Type A (Azzalure)
DEVICE: Restylane ranges

Sponsor

Galderma R&D